VialCurrently out of stock
Tirzepatide
Dual agonist (GLP-1 / GIP) research peptide
Dual-incretin signallingMetabolic-pathway comparison
€0.00SKU: AV-TIRZ-V15
1
Launching this quarter
Certificate of Analysis includedUK & EU cold-chain dispatchIn vitro research use only
Research pathwayTirzepatide · catalogued focus areas
Dual-incretin signallingMetabolic-pathway comparison
2 active research areas · 99.2% (HPLC)Batch AVC-2603-0117
Research description
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its combined effect on metabolic signalling pathways. Launching this quarter — supplied as a lyophilized powder in a single-use vial, with an independent Certificate of Analysis on every batch. In vitro laboratory research use only.
- Dual GIP/GLP-1 receptor agonist for combined-pathway research
Regulatory notice
This product is supplied strictly for in vitro laboratory and analytical research. It is not intended for human or veterinary use, and is not a drug, food, or cosmetic under UK or EU law.
Read the full disclaimer→You may also research
PREMIUM
Vial · Weight Management
Retatrutide
Triple-agonist GLP-1/GIP/glucagon research peptide
from€129.99In stock
Pre-filled Pen · Weight Management
Retatrutide Pen
Pre-filled, dose-locked triple-agonist GLP-1/GIP/glucagon pen
from€249.99In stock
Out of stock
Vial · Weight Management
Semaglutide
GLP-1 receptor agonist research peptide
€69.99Out of stockNext batch ~10 days